Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Correction

Correction to: Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion

Authors: Shuangmei Ye, Xing Hao, Ting Zhou, Mingfu Wu, Juncheng Wei, Yongjun Wang, Li Zhou, Xuefeng Jiang, Li Ji, Yin Chen, Lanying You, Yiqun Zhang, Gang Xu, Jianfeng Zhou, Ding Ma, Shixuan Wang

Published in: BMC Cancer | Issue 1/2019

Login to get access

Excerpt

Correction to: BMC Cancer (2010) 10:611 …
Literature
1.
Metadata
Title
Correction to: Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion
Authors
Shuangmei Ye
Xing Hao
Ting Zhou
Mingfu Wu
Juncheng Wei
Yongjun Wang
Li Zhou
Xuefeng Jiang
Li Ji
Yin Chen
Lanying You
Yiqun Zhang
Gang Xu
Jianfeng Zhou
Ding Ma
Shixuan Wang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-6367-9

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue

Research article

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review

Research article

Differential proteomic comparison of breast cancer secretome using a quantitative paired analysis workflow

Research article

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy

Research article

The release of tryptase from mast cells promote tumor cell metastasis via exosomes

Research article

Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments

Research article

Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits